[CBPO] China Biologic Products, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 111.28 Change: 0.93 (0.84%)
Ext. hours: Change: 0 (0%)

chart CBPO

Refresh chart

Strongest Trends Summary For CBPO

CBPO is in the long-term up 1381% in 15 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: China Biologic Products, Inc., a biopharmaceutical company, is engaged in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. It offers human albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human albumin and human immunoglobulin for intravenous injection (IVIG) products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides injection for the treatment of original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseas

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS4.79 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y64.77% Sales Growth - 4 Quarters 17.11% Sales Growth - Q/Q21.33% P/E23.04
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA17.23% ROE32.01% ROI
Current Ratio2.51 Quick Ratio1.67 Long Term Debt/Equity Debt Ratio0.52
Gross Margin66.28% Operating Margin45.83% Net Profit Margin29.46% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-2.16 M Cash From Investing Activities-8.47 M Cash From Operating Activities16.54 M Gross Profit45.89 M
Net Profit23.16 M Operating Profit34.75 M Total Assets440 M Total Current Assets308.42 M
Total Current Liabilities122.71 M Total Debt66.3 M Total Liabilities203.14 M Total Revenue70.35 M
Technical Data
High 52 week106.72 Low 52 week60.38 Last close81.46 Last change0.82%
RSI59.34 Average true range1.84 Beta0.44 Volume79.23 K
Simple moving average 20 days1.59% Simple moving average 50 days4.1% Simple moving average 200 days-2.28%
Performance Data
Performance Week-0.09% Performance Month1.83% Performance Quart7.89% Performance Half-18.56%
Performance Year-2.7% Performance Year-to-date7.31% Volatility daily1.42% Volatility weekly3.17%
Volatility monthly6.5% Volatility yearly22.53% Relative Volume213.12% Average Volume142.97 K
New High New Low

News

2019-03-22 04:10:08 | New Strong Sell Stocks for March 22nd

2019-03-20 07:23:11 | New Strong Sell Stocks for March 20th

2019-03-19 08:30:15 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-18 10:47:02 | New Strong Sell Stocks for March 18th

2019-03-12 10:28:12 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-07 15:21:43 | China Biologic Products Inc CBPO Q4 2018 Earnings Conference Call Transcript

2019-03-06 17:00:00 | China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018

2019-02-25 08:00:00 | China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results

2019-02-04 13:06:31 | Dalton Investments’ Return, AUM, and Holdings

2019-01-31 08:02:41 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-29 08:02:42 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-15 08:01:46 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-09 08:01:47 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-07 08:00:00 | China Biologic Reiterates Full Year 2018 Financial Forecast

2018-12-22 08:01:40 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-12-17 10:05:00 | David Gao Issues Statement Following Decision by the Grand Court of the Cayman Islands

2018-12-14 08:00:00 | China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman

2018-12-13 06:55:00 | Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and China Biologic Products Holdings

2018-11-24 08:05:17 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-11-20 08:05:20 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-11-01 19:20:33 | China Biologic Products: 3Q Earnings Snapshot

2018-11-01 16:30:00 | China Biologic Reports Financial Results for the Third Quarter of 2018

2018-10-25 08:04:26 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-10-24 08:00:00 | China Biologic Products to Report Third Quarter 2018 Financial Results

2018-10-23 08:04:54 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-10-04 12:48:10 | Investor Criticizes China Biologic Over Rejected Takeover Bid

2018-09-26 07:50:00 | Research Report Identifies The Carlyle Group, China Biologic Products, Ericsson, Dover, GasLog Partners LP, and Spectra Energy Partners, LP with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-09-25 08:05:17 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-09-24 09:44:11 | Is China Biologic Products Inc. CBPO A Good Stock To Buy? Centurium Capital Thinks So

2018-09-22 08:03:31 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-08-29 11:59:00 | David Gao Confirms Lawsuit Against China Biologic Products to Protect Shareholders’ Best Interests

2018-08-28 17:00:00 | China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman

2018-08-25 08:03:43 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-08-24 13:47:50 | China Biologic rejects $3.9 bln bid from former CEO

2018-08-24 12:35:00 | Leading Investor Group Issues Statement Following China Biologic’s Dilutive Private Placement of Shares

2018-08-24 11:43:10 | [$$] China Biologic Says One Buyout Offer Is Withdrawn, Rejects Another

2018-08-24 11:26:58 | Here's Why China Biologic Products Stock Dropped Today

2018-08-24 10:43:23 | BRIEF-PW Medtech Group To Purchase 800,000 China Biologic Products Shares For $80.72 Mln

2018-08-24 08:00:00 | China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement

2018-08-21 16:05:49 | Deals of the day-Mergers and acquisitions

2018-08-21 08:00:00 | China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal

2018-08-21 08:00:00 | Today's Research Reports on Trending Tickers: Cronos and China Biologic Products

2018-08-21 04:46:44 | China Biologic gets $3.9 bln offer from former CEO-led consortium

2018-08-20 13:52:55 | Here's Why China Biologic Products Stock Is Soaring Today

2018-08-20 13:35:04 | China Biologic gets $3.9 billion offer from former CEO-led consortium

2018-08-20 12:26:18 | UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium

2018-08-20 08:38:00 | Consortium seeks to acquire China Biologic Products for $3.9 billion in cash

2018-08-20 08:30:00 | Leading Investor Group Proposes to Acquire China Biologic Products for US$118.00 Per Share in Cash

2018-08-14 08:02:03 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-08-13 08:00:00 | China Biologic Names Bing Li as New CEO